Home/Orbus Therapeutics/Noymi Yam, PhD
NY

Noymi Yam, PhD

Vice President, Chief Scientific Officer

Orbus Therapeutics

Therapeutic Areas

Orbus Therapeutics Pipeline

DrugIndicationPhase
EflornithineAnaplastic Astrocytoma (AA3 / Grade 3 Glioma)Phase 3